Economic analysis of one-month cost and long-term medication of Sunitinib

Sunitinib (Sunitinib) is a multi-target tyrosine kinase inhibitor that is widely used in the treatment of renal cell carcinoma, gastrointestinal stromal tumors and some pancreatic neuroendocrine tumors. The drug is currently on the market in China and is included in the scope of medical insurance reimbursement. Patients can buy it with a prescription at regular domestic hospital pharmacies, which reduces the difficulty and financial burden of drug purchase.

From a price point of view, the original drug of sunitinib in China is relatively expensive. Taking the specifications of 12.5mg*28 tablets as an example, the cost of a box is about several thousand yuan. According to the common therapeutic dosage (such as 50mg/days, take it continuously for 4 weeks and then stop taking it 2 weeks of treatment) may require more than 4 boxes a month, and the actual cost is about 2 yuan. Due to medical insurance coverage, the reimbursement ratio in different regions is usually between 50% and 70%. The actual out-of-pocket cost of the patient is about 6,000 to 10,000 yuan. The specific situation needs to be confirmed based on the local medical insurance policy.

For patients taking medication for a long time, the financial burden still cannot be ignored. Although medical insurance reimbursement can significantly reduce costs, the cumulative expenditure is still high due to the long treatment period. This is also the reason why many patients will consider purchasing generic drugs through overseas channels. Foreign generic drugs mainly come from Laos and India, with obvious price advantages. The price of generic drugs with common specifications of 12.5mg*28 tablets is only about more than 100 yuan. The overall ingredients are basically the same as the domestic original drugs, so they are more economically attractive.

Overall, sunitinib's domestic accessibility and reimbursement policies have improved patients' treatment opportunities, but the economic burden of long-term medication is still high. For patients with limited financial conditions, they can choose to purchase generic drugs through formal channels under the guidance of a doctor to reduce expenses. However, whether you choose domestic medical insurance original drugs or overseas generic drugs, you need to ensure the safety of the drugs to avoid affecting the efficacy and health due to unknown drug sources.

Reference materials:https://www.drugs.com/